Fortrea Site Advisory Board
Collaborating with sites to deliver bold solutions in clinical trial delivery
Listening more intently to sites, the Fortrea Site Advisory Board (SAB) delivers a novel opportunity to partner with sites and deliver bold solutions to site burden, protocol design, startup times, site choice and patient recruitment. By adding valuable site insights through our SAB relationships, we bring game-changing contributions to you about the design and delivery of your clinical trials.
Collaborating for better design
Better for patients means better recruitment and retention. Better for sites means better startup time lines and more transparency in delivery promises.
Advancing operations
Collectively, we’re bringing fresh, bold solutions to minimize site burden and maximize trial efficiency.
Technology solutions that work
We’re listening to what sites need so that we help rather than hinder site operations. We stop, listen and innovate to bring sites genuine solutions.
Listening, learning, collaborating
We collaborate with the SAB toward solutions to solve clinical research challenges, from protocol design and patient-focused drug development to technology use and the inclusion of difficult to reach populations.
We bring fresh thinking and new perspectives from large and small sites and drug developers, as well as members from different global regions and backgrounds.
Together, we pursue opportunities for streamlining clinical trial operations, optimizing study design and implementing innovative technologies. Pulling from our collective expertise and insights, the board helps us develop strategies that provide tangible results, enhancing the clinical trial experience for sponsors, sites and patients. It all adds up to a diverse mix of input that helps us develop and share best practices and novel solutions to make trials better.
VideoInterested in becoming a Fortrea Site Advisory Board member?
We welcome perspectives from around the world, and from across different therapy areas. With new contributors joining and previous contributors stepping back, we are keen to continue to keep our thinking fresh.
If you are interested in contributing to the Fortrea Site Advisory Board’s wealth of industry expertise, please get in touch.
“Thank you” to our partner sites
We extend our deepest gratitude to our valued partner sites for their unwavering commitment to advancing clinical research. Your commitment is the cornerstone of our collective success, and we appreciate your far-reaching contributions:
- Driving innovation: Your collaboration fuels groundbreaking research and drives innovations that change lives
- Enhancing patient lives: Together, we bring life-changing therapies to patients, improving their quality of life
- Pioneering progress: Your commitment to excellence helps propel us forward on our bold mission to transform clinical trials for the benefit of sites, sponsors and patients
We are proud to stand by your side, working together to make a meaningful impact in clinical research. Thank you for your dedication to the pursuit of medical advancement.